SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-19-003459
Filing Date
2019-06-05
Accepted
2019-06-04 20:25:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A a2238964zs-1a.htm S-1/A 481380
2 EX-1.1 a2238964zex-1_1.htm EX-1.1 132604
3 EX-3.1(G) a2238964zex-3_1g.htm EX-3.1(G) 109511
4 EX-4.1 a2238964zex-4_1.htm EX-4.1 126557
5 EX-5.1 a2238964zex-5_1.htm EX-5.1 10352
6 EX-10.12 a2238964zex-10_12.htm EX-10.12 256230
7 EX-23.1 a2238964zex-23_1.htm EX-23.1 2362
8 G101652KSI001.GIF g101652ksi001.gif GRAPHIC 16872
  Complete submission text file 0001047469-19-003459.txt   1143385
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-231604 | Film No.: 19878334
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences